Author Correction: Early response evaluation by single cell signaling profiling in acute myeloid leukemia.

Autor: Tislevoll BS; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Hellesøy M; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Fagerholt OHE; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Gullaksen SE; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway., Srivastava A; Genome Core Facility, Clinical Laboratory, K2 Haukeland University Hospital, Bergen, Norway., Birkeland E; The Proteomics Facility of the University of Bergen (PROBE), University of Bergen, Bergen, Norway., Kleftogiannis D; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Ayuda-Durán P; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway., Piechaczyk L; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Faculty of Medicine, University of Oslo, Oslo, Norway., Tadele DS; Department of Molecular Genetics, Division of Laboratory Medicine, Oslo University Hospital, Oslo, Norway.; Department of Translational Hematology and Oncology Research, Cleveland Clinic, OH, 44106, USA., Skavland J; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Baliakas P; Department of Immunology, Genetics and Pathology, Science for Life Laboratory, Uppsala University, Uppsala, Sweden., Hovland R; Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway., Andresen V; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway., Seternes OM; Department of Pharmacy, UiT-The Arctic University of Norway, 9037, Tromsø, Norway., Tvedt THA; Department of Hematology, Oslo University Hospital, Oslo, Norway., Aghaeepour N; Department of Anesthesiology, Perioperative and Pain Medicine, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Pediatrics, Stanford University School of Medicine, Stanford, CA, 94121, USA.; Department of Biomedical Informatics, Stanford University School of Medicine, Stanford, CA, 94121, USA., Gavasso S; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway.; Centre for Clinical Treatment Research (NeuroSysMed), Department of Clinical Science, University of Bergen, Bergen, Norway., Porkka K; Department of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland., Jonassen I; Centre for Cancer Biomarkers and Computational Biology Unit, Department of Informatics, University of Bergen, Bergen, Norway., Fløisand Y; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Department of Hematology, Oslo University Hospital, Oslo, Norway., Enserink J; Department of Molecular Cell Biology, Institute for Cancer Research, The Norwegian Radium Hospital, Montebello, 0379, Oslo, Norway.; Centre for Cancer Cell Reprogramming, Institute of Clinical Medicine, Faculty of Medicine, University of Oslo, 0318, Oslo, Norway.; Section for Biochemistry and Molecular Biology, Faculty of Mathematics and Natural Sciences, University of Oslo, 0037, Oslo, Norway., Blaser N; Department of Informatics, University of Bergen, Bergen, Norway. nello.blaser@uib.no., Gjertsen BT; Centre for Cancer Biomarkers (CCBIO), Department of Clinical Science, University of Bergen, Bergen, Norway. bjorn.gjertsen@uib.no.; Department of Internal Medicine, Hematology Section, Haukeland University Hospital, Helse Bergen HF, Bergen, Norway. bjorn.gjertsen@uib.no.

Publikováno v: Nature communications [Nat Commun] 2023 Mar 30; Vol. 14 (1), pp. 1767. Date of Electronic Publication: 2023 Mar 30.

Repurposing chlorpromazine for anti-leukaemic therapy by nanoparticle encapsulation.

Autor: Gundersen ET; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway; Hospital Pharmacies Enterprise, Western Norway, Bergen, Norway., Førde JL; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway; Department of Internal Medicine, Haukeland University Hospital, Bergen, Norway., Tislevoll BS; Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Leitch C; Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Barratt G; Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Châtenay-Malabry, France., Gjertsen BT; Centre of Cancer Biomarkers CCBIO, Department of Clinical Science, University of Bergen, Bergen, Norway., Herfindal L; Centre for Pharmacy, Department of Clinical Science, University of Bergen, Bergen, Norway. Electronic address: lars.herfindal@uib.no.

Publikováno v: International journal of pharmaceutics [Int J Pharm] 2022 Jan 25; Vol. 612, pp. 121296. Date of Electronic Publication: 2021 Nov 15.